批准使用的癌症患者家庭測試套件

A new device called Liberty has been given regulatory approval to help cancer patients reduce the time they spend in the hospital. This innovative tool allows patients to take blood tests at home and upload the results without the need for supervision. According to users, it has the potential to minimize the number of hospital visits, which can be quite draining for patients. Clinicians also believe that it could enhance productivity within the NHS. Following successful trials at the Christie in Manchester, the device is set to be deployed at 12 NHS sites. Despite the positive feedback, Cancer Research UK has highlighted that the device has only been tested on a small number of people. Therefore, further research is necessary to determine its broader applicability in cancer care. The Liberty, which is about the size of a small printer, is capable of transmitting blood sample analysis directly to hospital teams. This transition to at-home blood testing is not only more convenient for patients but also has the potential to generate cost savings for the NHS. Entia, the company behind the device, is optimistic about its ability to provide valuable insights into patients' health status and reduce hospitalizations and treatment interruptions.